Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03795246

Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer

Long-term Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients Treated for a Breast Cancer

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
132 (estimated)
Sponsor
Centre Oscar Lambret · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Interventional research with low risks and constraints, prospective and monocentric on the assessment of long-term fertility in patients who underwent an adjuvant sequential chemotherapy with or without a controled ovarian hyperstimulation. This study follows a previous one called NCT 01614704.

Detailed description

The patients will have a follow-up once a year during ten years beginning at the end of their chemotherapy. They will have a consultation in oncology consisting of: * a clinical exam, * a collection and follow-up of oncological data * a collection of ongoing cancer treatments and a consultation in gynecology consisting of: * a pelvic ultrasound scan (for AFC: Antral Follicle Count) * a biological test (FSH, LH, E2, AMH) * a collection of gynecological data, contraception and reproductive medicine

Conditions

Interventions

TypeNameDescription
PROCEDUREConsultationConsultation in oncology: collection of oncological data and ongoing cancer treatments, clinical exam Consultation in gynecology: collection of gynecological data, contraception and reproductive medicine
BIOLOGICALBiological TestBlood test: * FSH, LH, E2 and AMH * 4 tubes of 7 mL
PROCEDUREPelvic UltrasoundAntral Follicles Count

Timeline

Start date
2018-04-12
Primary completion
2028-01-01
Completion
2028-01-01
First posted
2019-01-07
Last updated
2026-03-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03795246. Inclusion in this directory is not an endorsement.